Laidlaw & Company (UK) Ltd.
Tracked across 1 events · 6 articles · First seen Aug 07, 2026 · Last active Aug 10, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Femasys Inc., a biomedical company developing fertility and non-surgical permanent birth control solutions, announced on August 7, 2026 that it entered into a securities purchase agreement for a $30 million private placement with accredited investors.…
Impact: Laidlaw & Company acted as placement agent for the private placement, facilitating the transaction.
Aug 07, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Laidlaw & Company (UK) Ltd. live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard